Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells https://www.biorxiv.org/content/10.1101/2023.04.17.537215v1?med=mas
Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells https://www.biorxiv.org/content/10.1101/2023.04.17.537215v1?med=mas